Progress in clinical research on remazolam
10.12092/j.issn.1009-2501.2023.10.014
- Author:
Yuqi XIN
1
;
Ya CAO
2
;
Yulong WANG
2
Author Information
1. School of Anesthesiology, Wannan Medical College
2. Department of Anesthesiology, Yijishan Hospital, Wannan Medical College
- Publication Type:Journal Article
- Keywords:
remimazolam;
sedative;
ultra short acting benzodiazepine
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2023;28(10):1195-1200
- CountryChina
- Language:Chinese
-
Abstract:
Benzodiazepines are among the most commonly used drugs in the field of anesthesia. Remazolam is a newly developed ultra-short-acting benzodiazepine, which has the characteristics of rapid onset, rapid recovery, high safety, and less side effects such as hypotension and respiratory depression. The aim of this review is to summarize the progress of pharmacokinetics, clinical pharmacology mechanism of action and clinical application of remazolam.
